Hep Email Update Antiviral Treatment Reduces Complications and Death for People With Hepatitis C People treated with direct-acting antivirals had a lower risk of liver failure and liver cancer as well as much lower mortality. One Third of People Who Drop Out of Hepatitis C Care Can Be Reengaged in Treatment ReLink programs treated 19% of people who were brought back into HCV care after being lost to follow-up. NIH Launches Harm Reduction Research Network to Prevent Overdose Fatalities Scientists will test community-based approaches to prevent drug overdoses and curb high death rates. Advertisement Liver Cancer Is Expected to Rise 55% by 2040 Experts predict that more than a million people could die from liver cancer worldwide in 2040. Few Americans are Aware of Links Between Alcohol and Cancer Risk Awareness varied between wine, beer and liquor. Hep A Outbreaks Our map outlines where in the United States active cases of hepatitis A have been reported in the past 12 months on a scale from 0 to 100 relative to other states. Advertisement Science News Antiviral Treatment Reduces Complications and Death for People With Hepatitis C Liver Cancer Is Expected to Rise 55% by 2040 Paxlovid Reduces Serious Risks from COVID Omicron Variants Most Countries Not on Track to Eliminate Hepatitis B and C by 2030 Newsfeed HIV, HBV, HCV Testing Increased Among Medicaid Enrollees Few Americans are Aware of Links Between Alcohol and Cancer Risk NIH Launches Harm Reduction Research Network to Prevent Overdose Fatalities U.S. Looks to Implement One-Step Hepatitis C Diagnosis Science News Antiviral Treatment Reduces Complications and Death for People With Hepatitis C Liver Cancer Is Expected to Rise 55% by 2040 Paxlovid Reduces Serious Risks from COVID Omicron Variants Most Countries Not on Track to Eliminate Hepatitis B and C by 2030 Newsfeed HIV, HBV, HCV Testing Increased Among Medicaid Enrollees Few Americans are Aware of Links Between Alcohol and Cancer Risk NIH Launches Harm Reduction Research Network to Prevent Overdose Fatalities U.S. Looks to Implement One-Step Hepatitis C Diagnosis

You are receiving this email because you opted in at one of our websites. At your request, this message was sent to newsletter@newslettercollector.com by update@hepmag.com. Please remember to add update@hepmag.com to your email address book, so that these updates aren't blocked as spam.

To change your subscription information and preferences, please visit your personal preferences page. Or you can unsubscribe completely from this list.

To forward this message, please do not use the forward button of your email application, because this message was made specifically for you only. Instead use the forward page in our newsletter system.

Did you receive this email from a friend? You can subscribe and you will receive our next newsletter directly to your inbox.

Our mailing address is: